Gland Pharma

Buy Gland Pharma; target of Rs 2310: Motilal Oswal

Motilal Oswal is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 2310 in its research report dated November 04, 2025.

Chartist Talk: Has Nifty 50 entered the third wave of its uptrend to reclaim record highs by Diwali?

Ashok Leyland has been in a structural uptrend. The stock has also given a breakout of the Rounding bottom pattern which is a strong bullish sign, says Ashish Kyal.

Trade Spotlight: How should you trade Berger Paints, Cholamandalam Financial, Havells, Amara Raja Energy, Prostarm Info, Jayaswal Neco, and others on September 12?

The market is expected to extend its bullish bias, given favourable technical and momentum indicators. Below are some short-term trading ideas to consider.

Indian CRDMOs at turning point: Jefferies initiates coverage on Cohance, upgrades Divi’s

Jefferies said India’s CRDMO sector is at a global inflection point, with structural growth ahead on China+1 tailwinds and strong drug pipelines.

Buy Gland Pharma; target of Rs 2340: Motilal Oswal

Motilal Oswal is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 2340 in its research report dated August 06, 2025.

Cenexi turnaround brings Gland Pharma close to growth revival

Gland Pharma’s full year earnings are estimated to rise in FY26 after three consecutive years of declines

Stocks to Watch Today: NSDL, Sri Lotus Developers, Bharti Airtel, Britannia, Lupin, Prestige Estates, EIH, Gland Pharma, HG Infra in focus on 6 August

Stocks to Watch Today, 6 August: Stocks like National Securities Depository, Sri Lotus Developers, M&B Engineering, Bharti Airtel, Britannia Industries, Lupin, Prestige Estates Projects, EIH, Gland Pharma, and HG Infra Engineering will be in focus on August 5.

Stocks to Watch Today: DMart, NCC, Kolte Patil, VIP Industries, Sula Vineyards, Wockhardt, Akzo Nobel, Gland Pharma, Travel Food Services in focus on 14 July

Stocks to watch, 14 July: Stocks like Avenue Supermarts, NCC, Kolte-Patil Developers, VIP Industries, Sula Vineyards, Wockhardt, Akzo Nobel India, Gland Pharma, and Travel Food Services will be in focus on July 14.

Stocks to Watch Today: NTPC Green, Diamond Power Infra, Newgen Software, Indosolar, Gland Pharma, Hindustan Aeronautics in focus on 5 June

Stocks to Watch, 5 June: Aditya Birla Fashion and Retail, Manappuram Finance, Jindal Saw, Rallis India, Yes Bank, NTPC Green Energy, Diamond Power Infrastructure, Newgen Software Technologies, Indosolar, Gland Pharma, and Hindustan Aeronautics will be in focus on June 5.

Stocks to Watch Today: Wipro, HDFC Bank, Alkem Labs, Aditya Birla Fashion, Indegene, Tata Technologies, Servotech, Scoda Tubes in focus on 4 June

Stocks to watch, 4 June: Stocks like Sun Pharmaceutical Industries, Zydus Lifesciences, Techno Electric & Engineering Company, R Systems International, NMDC, Tata Technologies, Indegene, Aditya Birla Fashion and Retail, Alkem Laboratories, HDFC Bank, Wipro, Servotech Renewable Power Systems, and Scoda Tubes will be in focus on June 4.

Stocks to Watch Today: NHPC, United Spirits, Aster DM Healthcare, GSFC, Gland Pharma, KPR Mills, Dixon Tech, IRCON, Nazara Tech in focus on 21 May

Stocks to Watch, 21 May: Stocks like Gland Pharma, Dixon Technologies, KPR Mills, IRCON International, Nazara Technologies, Edelweiss Financial Services, Protean eGov Technologies, Axiscades Technologies, Accretion Pharmaceuticals, NHPC, United Spirits, Aster DM Healthcare, and Gujarat State Fertilizers & Chemicals will be in focus on May 21.

Gland Pharma shares rise most in 16 weeks, with US FDA's pre-approval inspection at its JNPC facility

Business daily Livemint had reported earlier this in February citing sources that Blackstone, Brookfield, and Warburg Pincus were in talks to acquire a majority stake in Gland Pharma, a maker of generic injectables.

Blackstone, Brookfield, Warburg Pincus in talks for majority stake in Gland Pharma, says report

The deal between the three global private equity majors and China’s Shanghai Fosun Pharma - which owns a majority stake in the company - is likely to value the company at around $3 billion, the report added.

Buy Gland Pharma; target of Rs 1840: Motilal Oswal

Motilal Oswal is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 1840 in its research report dated February 03, 2025.

Brokerage Radar: Divi's Labs, Paytm receive positive calls but LIC Housing Fin gets mixed calls

Check out the latest brokerage calls and analyst comments on the stocks in action today. Our coverage includes LIC Housing Finance, Divi's Labs, Gland Pharma, ONGC and Aster DM, among others.

Gland Pharma Q3 results: Net profit rises 7% to Rs 205 crore as expenses drop

Production setbacks at Cenexi's sites in Paris and Belgium and hurt revenue, Gland Pharma said

Castrol India, Gland Pharma not eligible to enter F&O, NSE modifies previous order

A circular modifying the previous intimation, dated January 7, was shared by NSE, citing incomplete 'eligibility criteria' as the reason behind the decision to exclude.

Gland Pharma gets EIR from USFDA for Pashamylaram facility; shares trade flat

Gland Pharma Share Price | The company is going to announce its earnings for the quarter and nine months ended December 31, 2024 on February 3, 2025. The share touched a 52-week high of Rs 2,220.95 and a 52-week low of Rs 1,590.00 on 06 August, 2024 and 24 October, 2024, respectively.